NCT01076543 2019-10-16Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 1/2 Completed110 enrolled 17 charts